Milbank, Tweed, Hadley & McCloy, LLP represented Catalyst in the transaction. Catalyst and SXC are pharmacy benefits managers that contract with drug companies and pharmacies to dispense medicine and process claims. The combined company, which was rendered Catamaran Corp., is the forth largest pharmacy benefits management company in the United States with approximately $13 billion in annual revenue and 25 million covered members, responsible for more than 200 million prescriptions written each year.
The Milbank team was led by New York-based partner Thomas Janson and included of counsel David Schwartz and associates George Esposito and Nehal Siddiqui from the Global Corporate Group; with tax support provided by partner Russell Kestenbaum, employee benefits support provided by partner Paul Wessel and associate Nicole Leyton Rosser; and litigation support provided by partner Alan Stone and associate Mia Korot.
